Remove 2018 Remove Government Remove Medical Remove Provider
article thumbnail

An Additional Physician from Leading Sarasota Cardiology Practice to Now Offer the Hybrid Choice™ Concierge Program from Concierge Choice Physicians

Concierge Choice Physicians

The physician continues to accept insurance and government programs, as before. They receive enhanced support and service from staff members, and medical advocacy and coordination with other health providers the patient may see. The patient decides what’s right for them. For more information, please visit www.ccpmd.com.

article thumbnail

‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warns

Physician's Weekly

Tianeptine is sold in a number of countries as a government-approved treatment for depression. But the FDA has never approved it for any medical condition in the U.S. Calello explained that it falls under a gray area of consumer supplements or products that are not regulated or tested the same way a medication would be.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law

Cato — On December 10, 2021, FDA issued a discussion paper titled 3D Printing Medical Devices at the Point of Care seeking feedback on FDA regulatory oversight of various 3D-printing scenarios, in order to inform future policy development. products intended for medical purposes). By McKenzie E.

Medical 98
article thumbnail

Green Practice News: April 2025

My Green Doctor

New Research: Teaching Patients about Climate Resilience Newly published original research co-authored by My Green Doctor’s Dr. Todd Sack concludes that, “ the medical office waiting room appears to be an accepted, time-efficient, and effective site to communicate knowledge on climate change and health. ” Contact us today! of total U.S.

article thumbnail

FDA Publishes Discussion Paper Seeking Feedback on 3D Printing of Medical Devices at the Point of Care

FDA Law

Cato — On December 10, 2021, FDA issued a discussion paper titled 3D Printing Medical Devices at the Point of Care seeking feedback on FDA regulatory oversight of various 3D-printing scenarios, in order to inform future policy development. products intended for medical purposes). By McKenzie E.

Medical 75
article thumbnail

Approaches for Quelling Stigma related to COVID-19

BMJ

7 Moreover, medical professionals, health practitioners, and relevant academic institutions should proactively disseminate creditable news and information during such health outbreaks through mainstream social media channels. Shaanxi, Xi’an, China: Shaanxi Normal University; 2018. 皖南医学院学报 [J Wannan Med Coll] 2010;29(05):391–94.

article thumbnail

FDA Publishes De Novo Classification Final Rule with Few Changes from the Proposed Rule

FDA Law

The Medical Device Amendments of 1976 created the initial premarket application (PMA) review and 510(k) substantial equivalence review processes. Only a year later, in 1977, FDA promulgated regulations governing 510(k) reviews (21 C.F.R. befitted a very important pathway to market for novel medical devices. Part 860.